II. Quality of Life
Quality of life (QOL) reported by patients with metastatic ocular melanoma comparing female versus male respondents. 10 responses 80 FEMALE (7 responses) 90 MALE (3 responses) QOL reported by patients with metastatic ocular melanoma comparing different metastatic tumor treatments. 9 responses 99 FOCAL ABLATION (1 response) 75 IMMUNOTHERAPY (3 responses)
PATIENT VOICE “Having been diagnosed with OM in 2019, I spent part of my career employed by our region’s cancer center as a clinical trials nurse. Through that experience, I learned first-hand about the sacredness of research participation. “I eagerly participated in the VISION not only because I’m grateful for the dedication of those who created the registry and CURE OM initiative, but because I recognize the importance of participation in being the primary way we advance to better treatments, prevention and a possible cure. If not to benefit ourselves, at the very least, it will benefit those who come after us, just as we stand on the shoulders of those patients who came before us.” — VISION Participant in USA
75
LIVER-DIRECTED THERAPY (3 responses)
90
SURGICAL RESECTION (2 responses)
2023 VISION Registry Data Report
36
Made with FlippingBook Ebook Creator